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.5 Autoimmunity and the endocrine system
Introduction
The immune system plays a vital role in protecting the body 
against attack from bacteria, viruses, and other foreign 
bodies. Essential to this function is its ability to distinguish 
between self  and non- self. Breakdown in this ability can 
occur, causing an inappropriate immune response against 
self- tissues and organs, known as autoimmunity. Endocrine 
autoimmunity is characterized by autoantibody production 
against components of  the endocrine system (Table .4), 
resulting in a variety of  conditions including, for example, 
type  diabetes, Graves’ disease, Hashimoto’s thyroiditis, 
Addison’s disease, and autoimmune polyendocrine syn-
drome type . Although, the exact organ/ s targeted for 
autoimmune attack vary from disease to disease, co- 
clustering of  different endocrine diseases within individuals 
and families, and the identification of  shared immunological 
genetic susceptibility loci between diseases, suggest the 
presence of  common pathogenic pathways. This section 
will focus on how disruption in immunological pathways 
contributes to disease onset.
Breakdown in ability to distinguish self 
from non- self
Constant monitoring of  antigens is performed by T 
lymphocytes and is essential to ensure that foreign 
antigens are recognized quickly and an immune response 
mounted. A T cell’s ability to distinguish self  from non- 
self  is key to this process and is achieved through central 
tolerance.
Central tolerance
CD4+ T helper (Th) cells, which activate B cells to 
produce antibodies, and CD8+ T cells, which produce 
cytotoxic T cells and natural killer (NK) cells, start off 
as common progenitor CD4−/ CD8− T cells within the 
bone marrow. Progenitor CD4−/ CD8− T cells undergo 
random rearrangement of  their T- cell receptor (TCR) 
gene, creating precursor CD4+/ CD8+ T cells. Random 
TCR rearrangements provide a mature T- cell repertoire 
capable of  binding a vast array of  antigens. Inevitably, 
however, some non- functional and self- / autoreactive 
precursor T cells are generated. Before entering the per-
ipheral immune system, precursor T cells move to the 
thymus to undergo selection.
Positive selection
Precursor CD4+/ CD8+ T cells’ TCR functionality 
is tested by determining binding to human leukocyte 
antigen (HLA) molecules presenting antigens. Precursor 
T cells that bind antigen- presenting HLA molecules re-
ceive a survival signal, whereas TCRs that do not bind 
receive no survival signal and so die.
Negative selection
Precursor T cells that survive positive selection are then 
retested to determine if  they bind HLA molecules pre-
senting an array of  self- antigens. Any T cells that recog-
nize self- antigens too strongly, suggesting autoreactivity, 
undergo TCR editing to alter antigen specificity or 
undergo apoptosis. Under normal circumstances, only 
functional, non- autoreactive CD4+/ CD8+ precursor T 
cells mature into CD4+ Th cells or CD8+ T cells and are 
released into the periphery.
Autoimmunity: A case of bad education?
Many endocrine antigens are expressed outside of  the 
thymus, raising the question as to whether precursor T 
cells have been educated to recognize them. The protein 
encoded by AIRE, defects in which were originally de-
tected as the genetic cause of  autoimmune polyendocrine 
syndrome type , was found to transcribe otherwise 
tissue- restricted antigens in the thymus, including sev-
eral thyroid and pancreas antigens. Support for a role 
of  disrupted central tolerance in autoimmune disease 
came from screening a variable number of  tandem re-
peats upstream of  the insulin gene in type  diabetes. 
The region consists of  4– 5 base pairs of  consensus 
sequence clustered into Class I (30– 60 repeats), Class II 
(60– 20 repeats), and Class III (20– 70 repeats) alleles. 
The presence of  Class  I  alleles predisposes for type  
diabetes, whereas presence of  Class  III alleles protects 
against type  diabetes. Functional studies demonstrated 
that Class  III alleles encode 200%– 300% higher insulin 
transcription in the thymus, compared to Class I alleles, 
suggesting that variation in the thymic transcript levels of  
endocrine genes could affect how successfully negative 
selection removes autoreactive T cells.
Disruption in antigen presentation to T cells
The constant processing and display of  antigens by HLA 
molecules on the surface of  antigen- presenting cells 
(APCs) in the periphery is essential for T- cell screening 
and, if  appropriate, the generation of  an immune re-
sponse (see Figure .5). Processing of  endogenous (in-
ternal) and exogenous (external) antigens is achieved 
through two distinct pathways. Endogenously derived 
proteins, including viral proteins, are initially ubiquitin-
ated and then degraded by the cytosolic pathway. This 
leads to the generation of  peptides which enter the 
endoplasmic reticulum, where they become bound by 
HLA class I molecules. Antigen- bound HLA class I mol-
ecules exit the endoplasmic reticulum and translocate 
to the APC surface for presentation to CD8+ T cells. 
If  the antigen is recognized as non- self, the CD8+ T cell 
becomes activated, leading to generation of  cytotoxic T 
cells, which destroy infected cells, and NK cell activation, 
which produce lymphokines, cytokines, and chemokines 
essential for immune cell recruitment and cell destruc-
tion. Exogenous proteins, such as those from bacteria, 
have to be internalized into the APC. Once internalized, 
Table .4 Different autoantigens identified in the endocrine 
autoimmune diseases
Breakdown in ability to distinguish self  from non- self
Disruption in antigen presentation to T cells
Alterations in T- cell activation/ signalling
Variation in B- cell function
Environmental impact on the immune system
Adapted from Wass JAH, Stewart PM, Amiel SA. et al., Oxford Textbook of  
Endocrinology and Diabetes, 2nd edition, Table .6.2, pp. 34– 44 Copyright 
© 20, with permission from Oxford University Press
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exogenous proteins navigate between a series of  in-
creasingly acidic compartments, known as the endocytic 
pathway, leading to the generation of  antigens. These 
antigens are bound by HLA class II molecules, which exit 
the endocytic pathway and are displayed on the APC sur-
face for recognition by CD4+ Th cells. If  the antigen is 
recognized as non- self, B- cell activation/ antibody pro-
duction and macrophage activation occurs. The vital role 
of  the HLA region in the immunological defence system 
is only possible because of  the highly variable nature of  
its encoding genes, which enable the human population 
to encounter and survive such a wide array of  antigenic 
threats. Some of  these variants, however, can predispose 
to the autoimmune disease process.
Variation in exogenous antigen presentation 
by HLA class II molecules
Variation within the HLA class  II region- encoded HLA- 
DR molecule (composed of  a HLA- DRB chain and 
the almost non- polymorphic HLA- DRA chain) and 
the HLA- DQ molecule (composed of  a HLA- DQB 
chain and a HLA- DQA chain) has been examined, 
with the DRB*03 variant being strongly associated with 
Graves’ disease and type  diabetes, and DRB*04 being 
strongly associated with type  diabetes and Hashimoto’s 
thyroiditis. Due to linkage disequilibrium among DRB, 
DQB, and DQA (see Chapter 4), the haplotypes con-
taining DRB*03 and DRB*04, known as the DR3 and 
DR4 haplotypes, respectively, are also strongly associated 
with autoimmune disease. Regression analysis of  DRB– 
DQB– DQA haplotypes in Graves’ disease revealed 
the association was due exclusively to DRB and DQA. 
When comparing the DRB*03 molecule, which pre-
disposes to Graves’ disease, to the DRB*07 molecule, 
which protects against Graves’ disease, change at amino 
acid position 74, from a positively charged arginine to a 
non- charged glutamine, respectively, was observed, in 
an area which forms part of  the HLA antigen- binding 
domain. Variation at position 74 also differentiated 
DRB*0403 and DRB*0406 molecules, which contain 
negatively charged glutamic acid at that position and 
confer a low risk for type  diabetes, from high- risk al-
leles, which contain non- charged polar amino acids at 
that position. Several hypotheses have been suggested to 
explain how variation in antigen- binding pockets of  HLA 
class II molecules could lead to autoimmune onset. These 
include:
•	 variation in the antigen- binding domain may cause 
preferential selection of  a limited set of  self- peptides 
during negative selection, allowing more autoreactive 
T cells to escape central tolerance
•	 preferential binding by a given DR/ DQ molecule in het-
erozygous individuals may lead to presentation of  spe-
cific antigens, depending on whether it is predisposing, 
neutral, or protective
•	 although HLA class  II molecules present exogenous 
antigens, cross- presentation of  endogenous antigens 
(normally presented by HLA class  I  molecules) can 
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Fig .5 The role of  T and B cells in monitoring antigens and mounting an immune response against any non- self  antigen; HLA, human 
leukocyte antigen; Th, T helper; NK, natural killer, CTL, cytotoxic T lymphocyte.
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occur, and vice versa, potentially altering how ex-
ogenous antigens are recognized by the immune 
system
Variation in endogenous antigen 
presentation by HLA class I molecules
Association of  HLA class  I  molecules, such as HLA- A, 
HLA- B, and HLA- C, with many autoimmune endocrine 
conditions has been detected, with several hypoth-
esis attempting to explain how they could be linked to 
autoimmunity:
•	 viral antigens preferentially presented by certain HLA 
class  I molecules may be similar to self- antigens; an 
immune response mounted against these antigens 
could unintentionally cross- react with similar 
self- antigens
•	 viruses presented by HLA class I molecules can trigger 
strong immune responses that could unintentionally 
cross- react with self- antigens
•	 HLA class  I  molecules interact with killer- cell 
immunoglobulin- like receptors which help control NK 
cell activation, and variation in these interactions could 
cause inappropriate NK cell activation
•	 variation in HLA class  I  molecules could cause alter-
ations in central tolerance mechanisms and affect T- cell 
education and/ or the production of  T regulatory cells
Variation in T- cell activation/ signalling
For T- cell activation to occur, this requires not only 
binding of  the TCR to the antigen presented by HLA mol-
ecules on the surface of  APCs, but also co- stimulatory 
signals. These signals come from accessory molecules 
such as CD28, which promotes signalling, and CTLA- 4, 
which downregulates signalling. CTLA- 4 is upregulated 
during T- cell signalling and has been proposed to block 
signalling through numerous pathways. These include the 
following:
•	 binding of  CD28 to co- stimulatory molecules CD80/ 
CD86 can be blocked by CTLA- 4
•	 CTLA- 4 can alter lipid raft and microcluster formation, 
thus aiding downstream TCR signal transduction
•	 co- factors required to enable the TCR to bind to 
antigens presented by HLA molecules and determine if  
the antigen is self  or non- self  are controlled by CTLA- 4
•	 CTLA- 4 also produces negative signals to prevent T- cell 
activation
•	 CTLA- 4 can alter the stability and strength of  TCR and 
APC interactions by decreasing adhesion molecules 
required for such interactions
Genetic variants within CTLA- 4 have been associated 
with multiple autoimmune disorders, including type 
 diabetes and Graves’ disease (see also Chapter  2, 
Section 2.4) and have been shown to alter the ratio 
of  full- length CTLA- 4 to a soluble isoform. As it has 
been suggested that the soluble isoform may provide 
greater inhibition of  T- cell activation than the full- 
length isoform, changes in the expression of  the soluble 
isoform could alter T- cell activation thresholds. Other 
inhibitors of  T- cell activation have also been associated 
with endocrine autoimmunity. Variation within PTPN22 
has been shown to encode a change from arginine to 
tryptophan at amino acid position 620 (referred to as 
R620W) of  the LYP molecule encoded by PTPN22. The 
presence of  the LYP620W variant has been shown to 
impair LYP interaction with Csk, an important intracel-
lular inhibitor of  the T- cell signal transducer Lck, causing 
greater inhibition of  T- cell signalling. The presence of  
LYP620W could lead to stronger downstream inhibition 
of  T- cell signalling, potentially altering autoreactive T- 
cell activity during central tolerance and thus affecting 
negative selection.
Although central tolerance removes the majority of  
autoreactive T cells before they enter the periphery, some 
autoreactive T cells do enter the periphery. T regulatory 
cells (a form of  CD4+ Th cells expressing high CD25 and 
foxp3 levels) account for 6%– 7% of  the mature CD4+ Th 
cell population and suppress the activation and expansion 
of  autoreactive T cells in the periphery. Not only could 
variation in CTLA- 4 and PTPN22 affect the function of  
T regulatory cells but variation in CD25 levels has been 
associated with Graves’ disease and type  diabetes. This 
leads to alterations in interleukin 2 binding (CD25 forms 
part of  the interleukin 2 receptor), which is involved in 
the development of  T regulatory cells and their ability 
to cause autoreactive T cells to undergo apoptosis. With 
evidence emerging for a role for foxp3 variation in auto-
immune disease onset, taken together this suggests alter-
ations in policing of  peripheral T- cell autoreactivity could 
contribute to autoimmunity.
Variation in B- cell function
For many years it has been postulated that B cells are 
merely involved in initiating autoimmunity by producing 
antibodies, whereas T cells progress disease. Increases in 
our knowledge of  B- cell function has identified additional 
roles in the immune system, including acting as APCs to 
CD4+ Th cells in low- antigen environments, controlling 
inflammation through cytokine production, and being 
directly activated by Toll- like receptor ligands, such as 
bacterial DNA, independently of  T cells and through 
the possible existence of  B regulatory cells. A  role for 
variation in molecules involved in B- cell signalling, such 
as B- cell activating factor and Fc receptor- like molecules, 
has been identified in disease, suggesting that the role of  
B cells in autoimmunity may be more complex than first 
envisaged.
Environmental impact on  
the immune system
It has been estimated that environmental factors make 
up >20% of  the contribution to endocrine disease, and 
several of  those identified, including viral and bacterial in-
fection, increased hygiene, stress, smoking, and early in-
take of  cow’s milk, have been proposed to alter immune 
function (Table .5).
Manipulating our understanding  
of immune disruption to create improved 
therapeutics
Insights into the immune dysfunction behind auto-
immune endocrine disease not only provide greater 
understanding of  disease onset and progression but also 
identify immune pathways upon which therapeutic inter-
vention could be undertaken. Whilst still in its infancy, im-
mune modulation in autoimmune disease pathways will 
undoubtedly in the future provide improved therapeutic 
options for these diseases.
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Table .5 Proposed environmental impacts on autoimmune endocrine disease and how they are believed to impact on the 
immune system
Environmental factor How environmental factor is proposed to alter immune system
Viruses and bacteria Birth rate data from type  diabetes and Graves’ disease patients show peaks in autumn and winter, 
when viruses and bacteria are more virulent, compared to birth rates peaks in the summer and 
spring in the general population; however, more recently, work in several large Caucasian Graves’ 
disease collections failed to show a peak in birth rates in summer and spring, casting doubt over the 
role of  month of  birth effects on autoimmune disease onset
Improved hygiene Humans have developed strong, highly effective immune systems to enable them to survive any 
foreign threat encountered; due to increases in hygiene, coupled with changes in social behaviour, 
the body is encountering less foreign insults and, as a result, our highly primed immune systems 
could turn against us, causing autoimmune onset
Stress and smoking These have immunosuppressive effects on the immune system by stimulating the hypothalamic– 
pituitary– adrenal axis, downregulating immune responsiveness and regulation
Exposure to cow’s milk early 
in life
Exposure to cow’s milk early in childhood, rather than breast milk, which provides immune 
support, has been proposed to contribute to type  diabetes, as the immune systems could trigger 
a response against cow insulin that may cross- react with human insulin; however, to date, no clear 
evidence of  a role for cow’s milk in increasing rates of  type  diabetes has been established
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